95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.20%
Revenue growth under 50% of FNV's 36.12%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-7.24%
Negative gross profit growth while FNV is at 36.54%. Joel Greenblatt would examine cost competitiveness or demand decline.
46.83%
EBIT growth below 50% of FNV's 480.92%. Michael Burry would suspect deeper competitive or cost structure issues.
46.83%
Operating income growth under 50% of FNV's 223.49%. Michael Burry would be concerned about deeper cost or sales issues.
22.02%
Net income growth under 50% of FNV's 560.76%. Michael Burry would suspect the firm is falling well behind a key competitor.
16.67%
EPS growth under 50% of FNV's 521.89%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
No Data
No Data available this quarter, please select a different quarter.
10.24%
Share count expansion well above FNV's 1.84%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
10.44%
Diluted share count expanding well above FNV's 2.74%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
14.42%
Positive OCF growth while FNV is negative. John Neff would see this as a clear operational advantage vs. the competitor.
27.48%
FCF growth under 50% of FNV's 127.89%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
75.71%
10Y revenue/share CAGR above 1.5x FNV's 8.00%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
No Data
No Data available this quarter, please select a different quarter.
-36.46%
Negative 3Y CAGR while FNV stands at 8.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
936.18%
Positive OCF/share growth while FNV is negative. John Neff might see a comparative advantage in operational cash viability.
-41.26%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
No Data
No Data available this quarter, please select a different quarter.
657.46%
5Y net income/share CAGR above 1.5x FNV's 149.46%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-46.67%
Negative 3Y CAGR while FNV is 149.46%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
2332.51%
5Y equity/share CAGR above 1.5x FNV's 14.36%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
60.11%
3Y equity/share CAGR above 1.5x FNV's 14.36%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
220.52%
AR growth well above FNV's 7.00%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
13.22%
Asset growth at 50-75% of FNV's 25.83%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
4.70%
Under 50% of FNV's 23.52%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-4.54%
We’re deleveraging while FNV stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-1.31%
We cut SG&A while FNV invests at 8.89%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.